the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Biotechnology Market Research

<< Previous Page:   3   4   5   6   7   8   9   10   11   12   13   14   Next >>
 
Biotech M&A Strategies: Deal assessments, trends and future prospects
Table of Contents Published: 2008/10 Published by: Business Insights
M&A activity in the pharma industry continues to gain momentum as a growing number of companies seek to replenish drug pipelines through biotechnology acquisitions. M&As between biotech companies are also growing in number, stimulated by the drive to stre ...

Organ and Tissue Transplantation and Alternatives
Table of Contents Published: 2008/10 Published by: BCC Research
This report offers forecasts by product segment from 2008 through 2013, including supporting analyses for projections. Product segments covered consist of solid organs (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation ...

Protein Drugs: Global Markets and Manufacturing Technologies
Table of Contents Published: 2008/10 Published by: BCC Research
Protein drugs have received enormous attention from pharmaceutical companies due to a combination of their bioreactivity, specificity, safety and overall success rate. Yet there are still improvements to be made, especially with respect to their formulati ...

Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
Table of Contents Published: 2008/09 Published by: La Merie
The report includes a compilation of current active projects in research and development of TLR agonists, antagonists, adjuvants and vaccines. ...

Emerging Medical Sensing Technologies
Table of Contents Published: 2008/09 Published by: Technical Insights, Inc.
This research service provides an overview of the emerging sensing technologies in the field of healthcare. ...

Gene Silencing Dashboard: Series Two
Table of Contents Published: 2008/09 Published by: Percepta Associates Inc.
RNA interference continues to emerge as a integral tool used to study the physiological role of gene products in vivo. RNAi-based methods allow researchers to modulate and in many cases virtually eliminate expression of a gene of interest. Systems for del ...

Orthopedic Medical Devices: Emerging Technologies and Trends
Table of Contents Published: 2008/09 Published by: Technical Insights, Inc.
This research service analyzes the global trends in the orthobiologics market with a focus on the current and prospective applications. ...

Biotechnology
Table of Contents Published: 2008/09 Published by: Global Industry Analysts, Inc.
The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird' s eye view of the Biotechnology industry. Annotated with 26 fact, and data rich ...

Global Antivirals Market Analysis & Forecasts 2008-2023
Table of Contents Published: 2008/09 Published by: Visiongain
Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs ...

Advances in Replacement Organs and Tissue Engineering
Table of Contents Published: 2008/09 Published by: Technical Insights, Inc.
The report discusses advances in replacement organs and tissue engineering. ...

Stem Cells in Regenerative Medicine 2008 Market Report
Table of Contents Published: 2008/09 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells space. ...

U.S. Stem Cell Market - Current Developments
Table of Contents Published: 2008/09 Published by: Frost & Sullivan
This research service covers the U.S. stem cell market: current developments. Included are a disease overviews for main indications, estimated patient penetration for main indications, technology trends,and total market potential. The market is segmented ...

Who's Developing What in Global Biopharmaceuticals?
Table of Contents Published: 2008/09 Published by: Espicom Business Intelligence
The biopharmaceutical R&D sector is taking an ever more important role in the minds of industry and investors. The potential to fundamentally alter treatment regimes and cure, rather than symptomatically treat, many life-threatening conditions grows great ...

How to Integrate Personalized Medicine into Business Strategies
Table of Contents Published: 2008/09 Published by: Decision Resources, Inc.
A growing awareness is taking hold across the pharmaceutical industry: what was once impossible - tailoring treatment to specifi c groups of patients rather than to the population as a whole - is becoming possible. ...

Pharma and the Feds: Key Government Activities and How They Affect the Biopharmaceutical Industry
Table of Contents Published: 2008/09 Published by: Decision Resources, Inc.
This is a critical time in U.S. history for examination of the delivery of healthcare services. Some 47 million people in the United States lack healthcare coverage; the country spends $2.2 trillion annually on healthcare; the United States ranks 37th in ...

Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
Table of Contents Published: 2008/09 Published by: Arrowhead Publishers
The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their ...

European Biosimilars Market Outlook
Table of Contents Published: 2008/09 Published by: Frost & Sullivan
This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various issues surrounding biosimilars, key drivers, restraints and challenges facing m ...

Obesity Drug Pipeline: Developing Therapies for a Complex Disease
Table of Contents Published: 2008/09 Published by: Insight Pharma Reports
The prevalence of overweight and obesity is increasing at an alarming rate worldwide, driven by social and economic changes. Obesity is involved in the pathogenesis of major diseases, especially diabetes and cardiovascular disease. Yet there are no suffic ...

Protein Research: Strategies for Marketing to Chemists and Biologists
Table of Contents Published: 2008/09 Published by: BioInformatics, LLC
A more in-depth understanding of the needs of scientists who are studying protein research is of growing importance as the field continues to become more complex and funding sources become harder to obtain. ...

U.S. Nucleic Acid Purification and Isolation Markets
Table of Contents Published: 2008/09 Published by: Frost & Sullivan
This research service analyzes the market for nucleic acid purification and isolation products within the United States. The market was divided into the nucleic acid purification and isolation consumables and nucleic acid purification and isolation instru ...

Successful Pharmabiotech Alliance Strategies: Driving synergies, avoiding failure and managing relationships
Table of Contents Published: 2008/09 Published by: Business Insights
In recent years, alliances between pharma and biotech companies have become common, with hundreds of relationships currently in place for drug developments across virtually all high priority conditions. Such alliances are of significant benefit to pharma ...

Cancer Drug Resistance 2008
Table of Contents Published: 2008/09 Published by: BioPharm Reports (Technology and Markets Ltd)
This new report includes i) A Global Resistance Map: a presentation and review of resistance mechanisms or resistance-associated changes at the gene, protein or functional level reported for currently approved cancer drugs, covering 60 general cancer drug ...

The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Table of Contents Published: 2008/09 Published by: Business Insights
RNA interference continues to offer significant promise for a host of therapeutic treatments. ...

Microarray Markets
Table of Contents Published: 2008/09 Published by: Trimark Publications
A microarray is an arrangement of miniaturized test sites or spots on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules--usually DNA or protein--which act as probes for a test sample applied to the ...

Discovery Stage Partnering Agreements in Biopharma
Table of Contents Published: 2008/09 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
The Discovery Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies. ...

Biomarkers: The Future of Next-Generation Drug R&D
Table of Contents Published: 2008/09 Published by: Takeda Pacific
This report analyzes the hot global market for biomarkers and related assays or tests used in drug R&D. The study reviews this dynamic market by looking at drug research and development spending trends, M&As, alliances, major diseases, applications, tools ...

Japan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2008/09 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to the Japan drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest n ...

United States In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012
Table of Contents Published: 2008/09 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to the United States In vitro diagnostic dvices market. ...

United States Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
Table of Contents Published: 2008/09 Published by: Global Markets Direct
This report is an essential source for in-depth information and data relating to the USA drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest new ...

Molecular Diagnostics Markets
Table of Contents Published: 2008/09 Published by: Trimark Publications
The technologies that constitute molecular diagnostics-first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels-a ...

Global Biotech Market Analysis and Forecasts, 2008-2023
Table of Contents Published: 2008/08 Published by: Visiongain
The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has ...

Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
Table of Contents Published: 2008/08 Published by: Insight Pharma Reports
Recent developments reflect the explosion in the number of kinase inhibitors that have entered clinical development in the past few years ...

US Markets for Orthopedic Biomaterials
Table of Contents Published: 2008/08 Published by: iData Research Inc.
In 2007, the orthopedic biomaterials market was valued at over $2.6 billion, growing at an associated CAGR of 12.9% by 2014.There is great promise in the future performance of the orthopedic biomaterials market. To date there has been a multitude of produ ...

IVD Market Research Supplement : Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics
Table of Contents Published: 2008/08 Published by: Kalorama Information
A bundle of five Kalorama Information reports, this resource, representing over 1,000 pages of information on cutting-edge topics critical to the future of diagnostics, is available at a significant discount over the cost of the five reports individually. ...

Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence
Part of Espicom' s new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cardiovascular biomarker sector, along with a critical assessment of the companies involved. ...

CNS Biomarkers Players, products and prospects
Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence
The CNS biomarker market represents one of the smallest segments of biomarkers in terms of revenue as relatively few CNS biomarkers are commercially available. In 2007, we estimate the CNS biomarker market accounted for less than 5% of biomarker revenues, ...

Cancer Biomarkers Players, products and prospects
Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence
The cancer biomarker market represents one of the largest segments of biomarkers in terms of revenue. In 2007, the estimated cancer biomarker market accounted for around 55% of biomarker revenues at over US$3 billion, with the majority of revenues derived ...

Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects
Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence
By 2015, the biomarker market is forecast to be worth over US$20 billion as the cardiovascular and CNS biomarker market segments begin to mature with the launch of a number of diagnostic tests to guide the treatment of neuropsychiatric and neurodegenerati ...

Evolving Trends in Licensing: Strategies for Building and Retaining Value in Biotechnology Alliances
Table of Contents Published: 2008/08 Published by: Decision Resources, Inc.
As the biotechnology industry continues to evolve and mature, many biotech companies are gaining more leverage in negotiating alliances. We analyzed recent deals and interviewed industry executives and experts to gain insight into current alliances and li ...

Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis
Table of Contents Published: 2008/08 Published by: BioSeeker Group AB
This report aims to analyze the current and future potential of breast cancer pipeline by examining key fundamentals across the entire pipeline of drug candidates. ...

Lessons Learned from the Current Crop of Biotech Startups
Table of Contents Published: 2008/08 Published by: Decision Resources, Inc.
The initial public offering (IPO) market for biotech and specialty pharma companies has been nearly lifeless in 2008. Investment bankers are unimpressed by the performance of these companies, and money managers are reluctant to support a negative trend. T ...

Biosimilars Series: Stakeholder Analysis
Table of Contents Published: 2008/08 Published by: Datamonitor
Although Europe is leading the way, the biosimilar industry is very much in its infancy, with the perception of key decision makers critical to the initial rate of uptake. The opinion of key stakeholders, and the influence they wield, will therefore infor ...

Eastern European IVD Market
Table of Contents Published: 2008/08 Published by: Frost & Sullivan
This strategic analysis service provides a detailed analysis of the Eastern European IVD market. ...

European Therapeutic Monoclonal Antibody Markets
Table of Contents Published: 2008/08 Published by: Frost & Sullivan
This research service analyses the market landscape, revenue potential, market dynamics and trends in the monocloanl antibodies market focussing on five major markets in Europe. ...

DNA Sequencing: Emerging Technologies and Applications
Table of Contents Published: 2008/08 Published by: BCC Research
The study scope includes DNA sequencing technologies likely to be commercialized within the next five years. Sanger and next generation (non-Sanger sequencing) technologies are included. Each technology is analyzed to determine its market status, impact o ...

Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues
Table of Contents Published: 2008/07 Published by: Datamonitor
As advances in omics technologies enable the development of high value molecular diagnostics, neurological conditions represent an attractive target for diagnostic companies. In this report, Datamonitor identifies the diseases in which early detection wit ...

Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
Table of Contents Published: 2008/07 Published by: Datamonitor
At the forefront of novel technologies; momentum is steadily building for the development of stem cell products to address cardiovascular disease. The most active areas are those with high clinical unmet need heart failure, cardiomyopathy and ishemic hear ...

Therapeutic Monoclonal Antibodies Report 2008-2023
Table of Contents Published: 2008/07 Published by: Visiongain
This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a whole is suffering from single digit growth, thinner pipelines than before and pressure from an ever-aggressive generics ind ...

Key Issues to Consider When Bringing Biologics to Market in Europe and Japan
Table of Contents Published: 2008/07 Published by: Decision Resources, Inc.
In the past 25 years, more than 100 recombinant proteins and MAbs have reached the global market. ...

Next Generation Sequencing for Life Science R&D: Advancing to the $1,000 Genome
Table of Contents Published: 2008/07 Published by: Fuji-Keizai U.S.A., Inc.
This report examines the emerging, fast-growing worldwide market for next-generation genome sequencing systems and services. ...


<< Previous Page:   3   4   5   6   7   8   9   10   11   12   13   14   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.